DIPP seeks details on 3 cancer drugs for compulsory licencing
New Delhi: Kick starting the process for a possible issuance of compulsory licences for anti-cancer drugs, the DIPP has sought details from the Health Ministry regarding three medicines sold by multinationals Roche and Bristol-Myers Squibb in India to make them affordable.
The Health Ministry had approached the Department of Industrial Policy and Promotion (DIPP) last month for issuance of compulsory licences (CLs) for three anti-cancer drugs - trastuzumab, ixabepilone and dasatinib, which are very expensive.
"The DIPP has sent a set of 12-14 questions to the Health Ministry yesterday. The department wants more information on things like number of cancer patients in India; prices of these three drugs in domestic and international market; alternative drugs if available and name of manufacturers etc," sources told PTI.
The Health Ministry had expressed concerns over the exorbitant prices of the three drugs. While one vial (of 50 ml) of 40 mg Trastuzumab costs Rs 1,24,000, 60 tablets of 20mg each of dasatinib priced at Rs 1,17,220. Similarly, one vial of 45 mg of ixabepilone costs Rs 66,430.
The sources, however, said a decision on the drugs -- trastuzumab, ixabepilone and dasatinib -- the patent for which are held by Swiss drug major Roche and US-based drug maker Bristol-Myers Squibb, respectively, are unlikely to be taken in a hurry.
Under the Indian Patents Act, a CL can be issued for a drug if the medicine is deemed unaffordable by the government and grants permission to qualified generic drug makers to manufacture it.
As per WTO agreement also, a CL can be invoked by a national government allowing a company to produce a patented product without the consent of the patent owner in public interest.
The government had issued the first such licence in March last year. India`s patent office had granted a licence to Hyderabad-based drug maker Natco Pharma to make and sell a copy of Bayer Corporation`s patented cancer drug Nexavar by invoking the compulsory licensing provision of the country`s patent law.
Natco was allowed to sell the drug at a price not exceeding Rs 8,880 for a pack of 120 tablets required for a month`s treatment, as compared to a whopping Rs 2.80 lakh per month charged by Bayer for its patented Nexavar drug.
More from India
More from World
More from Sports
More from Entertaiment
- One year of Modi govt: PM promises to fulfil aspirations
- Watch: Mumbai cops find new secret agents in housewives!
- DNA: Sikh man in New Zealand removed his turban to help injured kid
- Hundreds die as heat wave continues in India
- 2G scam: Ex-TRAI chief alleges Manmohan Singh had warned him to cooperate
- Pranab Mukherjee defends Bofors scam, says it was just a media trial
- DNA: AIIMS doctor removes both kidneys of minor, claims she had only one
- Growing medical negligence in Delhi's AIIMS
- Salman Khan attends sister Arpita's wedding reception in Mandi
- Zee Media's mega survey on Modi govt
- Zee Media Exclusive: Vidya Balan chats about 'Hamari Adhuri Kahani'
- Para athlete Deepa Malik complains of callous service by Air India
- Smriti Irani visits Amethi, promises to pay insurance money to 25,000 women
- One year of Modi govt: Amit Shah addresses media
- Mumbai Film City shoot-out: CCTV footage help police arrest assailants
- One year of NDA govt: PM Modi writes open letter to nation, promises to transform India
- World optimistic about India: PM Narendra Modi on 1 year of NDA govt
- MSBSHSE Class 12th HSC results 2015 to be declared at 1pm tomorrow
- Arpita-Aayush wedding reception: Salman Khan spreads love in Mandi, says `hum aapke hain`
- Bharatiya Janata Party lacks majority for Ram Temple, Article 370: Amit Shah
- AAP govt moves resolution against MHA notification: As it happened
- Rahul Gandhi takes a dig at one year of Modi govt, wishes 'happy birthday' to 'suit-boot ki sarkar'
- Heatwave kills 90 more in Andhra, Telangana; toll crosses 800
- UBSE Results 2015 (ubse.uk.gov.in): Uttarakhand 12th Result 2015 to be announced today at 11 AM
- Gujjars adamant on holding talks in Bayana; rail tracks remain blocked
- CBSE 10th result to be declared tomorrow
- CBSE Class X Board Results 2015 to declared tomorrow
- CBSE Class 10 Board Result 2015 (cbse.nic.in, cbseresults.nic.in) postponed?
- Salman Khan's `Bajrangi Bhaijaan` teaser to be out in two days?
- What couldn't be done in last 10 years, NDA govt did in one year: Smriti Irani in Amethi